| Literature DB >> 31803432 |
Anil P Jagtap1,2, Lukas Kaltschnee1,2, Stefan Glöggler1,2.
Abstract
Hyperpolarization techniques hold the promise to improve the sensitivity of magnetic resonance imaging (MRI) contrast agents by over 10 000-fold. Among these techniques, para-hydrogen induced polarization (PHIP) allows for generating contrast agents within seconds. Typical hyperpolarized contrast agents are traceable for 2-3 minutes only, thus prolonging tracking-times holds great importance for the development of new ways to diagnose and monitor diseases. Here, we report on the design of perdeuterated 15N-containing molecules with longitudinal relaxation times (T 1) of several minutes. T 1 is a measure for how long hyperpolarization can be stored. In particular, we introduce two new hyperpolarizable families of compounds that we signal enhanced with para-hydrogen: tert-amine aniline derivatives and a quaternary pyridinium compound with 15N-T 1 of about 8 minutes. Especially the latter compound has great potential for applicability since we achieved 15N-polarization up to 8% and the pyridinium motif is contained in a variety of drug molecules and is also used in drug delivery systems. This journal is © The Royal Society of Chemistry 2019.Entities:
Year: 2019 PMID: 31803432 PMCID: PMC6839503 DOI: 10.1039/c9sc02970b
Source DB: PubMed Journal: Chem Sci ISSN: 2041-6520 Impact factor: 9.825
Scheme 1Syntheses of 15N-pyridinium derivative (A) and -aniline based (B) derivatives; MW: microwave.
15N-T1 values for pyridinium and phenylammonium compounds along with their reduced products using para-H2
|
| ||||
| X | Structure |
15N- | Mag. field in T | Solvent and temp. in K |
|
|
| 140 ± 20 | 7 | MeOD at 320 |
| 220 ± 30 | 7 | D2O at 353 | ||
|
|
| 240 ± 10 | 7 | MeOD at 320 |
| 360 ± 50 | 1 | MeOD at 320 | ||
| 570 ± 110 | 0.1 | MeOD at 320 | ||
| 380 ± 30 | 0.01 | MeOD at 320 | ||
| 120 ± 10 | 7 | D2O at 353 | ||
| 330 ± 20 | 1 | D2O at 353 | ||
| 500 ± 30 | 0.1 | D2O at 353 | ||
| 290 ± 20 | 0.01 | D2O at 353 | ||
|
|
| 570 ± 40 | 9.4 | MeOD at 298 |
|
|
| 150 ± 20 | 7 | MeOD : D2O at 320 |
| 90 ± 40 | 0.1 | MeOD : D2O at 320 | ||
|
|
| 420 ± 100 | 9.4 | D2O at 298 |
|
|
| Decomposed | — | — |
A general scheme of hyperpolarization followed by polarization transfer to 15N nuclei; X = 1 (R, R′ = pyridinium); X = 2 (R = phenyl, R′ = –CD3) and X = 3 (R = phenyl, R′ = –(CD3)2); Mag.: magnetic; temp.: temperature.
In the presence of 2 mM [Rh(dppb)(COD)][BF4].
In the presence of 0.5 mg mL–1 NAC@Rh.
PHIP enhancements by using the homogenous and heterogeneous catalysts
| Compd. |
1H |
15N | |
| PHIP (homogeneous) MeOD at 320 K |
| 11 ± 1.3 | 7.4 ± 0.6 |
|
| — | — | |
|
| — | — | |
| PHIP (heterogeneous) D2O at 353 K |
| 2.1 ± 1.2 | 2.3 ± 1.1 |
|
| 1.3 ± 0.2 | 0.8 ± 0.1 | |
|
| — | — |
Multiple products or decomposition.
Measured in MeOD : D2O (1 : 1) at 320 K. Compd.: compound.
Fig. 1Hyperpolarized 15N spectrum of 1a (blue) by using PHIP in D2O and thermally polarized 15N spectrum of the unsaturated precursor 1 (red) at 7 T. The inset shows the 15N-T1 relaxation data measured at 0.1 T, using a hyperpolarized sample of 1a which was collected using sample shuttling and small flip angle pulses (see ESI† for further details).